Age-related macular degeneration: new treatments show promise.
R
R
DuBosar
D017677:Age Distribution; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D006801:Humans; D007910:Lenses, Intraocular; D008268:Macular Degeneration / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D010789:Phototherapy; D011166:Porphyrins / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D012109:Research Support as Topic; D013792:Thalidomide / Q000627:therapeutic use; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D011166:Porphyrins; D011838:Radiation-Sensitizing Agents; C063166:tin etiopurpurin; D013792:Thalidomide